IMMUNE DESIGN CORP. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Revenues:
Other, net
Collaborative revenue
Licensing revenue
Product sales
Total revenues

Operating expenses:
Cost of product sales
Research and development
General and administrative
Total operating expenses
Loss from operations
Interest and other income
Change in fair value of convertible preferred stock warrant liability
Net loss
Unrealized gain (loss) on investments
Comprehensive loss
Basic and diluted net loss per share (in dollars per share)
Weighted-average shares used to compute basic and diluted net loss per share (in shares)

Comments